Mast Therapeutics, Inc. (MSTX)

[ak17072001]

It is already coming off low. Since it went up 50% yesterday and had a rsi in the 80s it was a profit selloff. The conference today will make or break this. A highly succesfull conference will do wonders. Some rating agencies have a price target as high as $2 which is not unreasonable. Long term holders if everything works correctly have a small chance of seeing earlier highs (much more than $10 per share) but that is a large risk.